NCT04597580View on ClinicalTrials.gov

Personalised Disease Monitoring in Metastatic Breast Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

97

Participants

Timeline

Start Date

May 8, 2019

Primary Completion Date

May 31, 2026

Study Completion Date

January 31, 2030

Conditions
Breast Cancer MetastaticEstrogen Receptor-positive Breast Cancer
Trial Locations (7)

Unknown

Department of Oncology, Sahlgrenska University Hospital, Gothenburg

Department of Oncology, Ryhov Hospital, Jönköping

Department of Oncology, Kalmar Hospital, Kalmar

Department of Oncology, Linköping University Hospital, Linköping

Department of Oncology, Södersjukhuset, Stockholm

Wigan Infirmary, Wrightington, Wigan and Leigh NHS Foundation Trust, Wigan

M20 4BX

The Christie NHS Foundation Trust, Manchester

All Listed Sponsors
collaborator

Sahlgrenska University Hospital

OTHER

lead

The Christie NHS Foundation Trust

OTHER

NCT04597580 - Personalised Disease Monitoring in Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter